Patents by Inventor Doyle H. Waggle
Doyle H. Waggle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7285297Abstract: The present invention is a composition comprising a plant sterol and a soy protein material and/or and isoflavone selected from genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides, where the plant sterol comprises at least 0.49% of the composition, by weight. The present invention is also a method for decreasing the blood concentration of total and LDL cholesterol in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone. The present invention is also a method for preventing or minimizing the development of atherosclerosis in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.Type: GrantFiled: June 13, 2003Date of Patent: October 23, 2007Assignee: Archer-Daniels-Midland CompanyInventors: Doyle H. Waggle, Susan M. Potter, Edna C. Henley
-
Publication number: 20040071800Abstract: The present invention is a method for decreasing the blood concentration of total and LDL cholesterol in a human in which a plant sterol and a soy hypocotyl material are co-administered to the human, where the plant sterol comprises at least 0.Type: ApplicationFiled: October 20, 2003Publication date: April 15, 2004Applicant: The Solae Company, LLC.Inventors: Doyle H. Waggle, Susan M. Potter, E. C. Henley
-
Patent number: 6706292Abstract: A health supplement composition is disclosed. The health supplement composition contains a solid health supplement material that is separated from a soy molasses material. The solid health supplement material contains at least two isoflavones where one of the isoflavones is either glycitein or glycitin.Type: GrantFiled: December 12, 2002Date of Patent: March 16, 2004Assignee: Solae, LLCInventors: Doyle H. Waggle, Barbara A. Bryan
-
Patent number: 6680381Abstract: A health supplement composition is disclosed. The health supplement composition contains a solid health supplement material that is separated from a condensed soy molasses material. The solid health supplement material contains at least two isoflavones where one of the isoflavones is either glycitein or glycitin.Type: GrantFiled: December 16, 2002Date of Patent: January 20, 2004Assignee: Solae, LLCInventors: Doyle H. Waggle, Barbara A. Bryan
-
Patent number: 6669952Abstract: A composition is provided comprising a plant sterol and a soy protein material and/or and isoflavone selected from genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides, where the plant sterol comprises at least 0.49% of the composition, by weight. The present invention is also a method for decreasing the blood concentration of total and LDL cholesterol in a human in which the plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone. Also provided is a method for preventing or minimizing the development of atherosclerosis in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.Type: GrantFiled: March 30, 2001Date of Patent: December 30, 2003Assignee: Solae, LLCInventors: Doyle H. Waggle, Susan M. Potter, E. C. Henley
-
Patent number: 6664382Abstract: A health supplement composition is disclosed. The health supplement composition contains a solid health supplement material that is separated from a soy molasses material. The soy molasses material is derived from a soy material selected from soy flour, soy flakes, soy grit, or soy meal. The solid health supplement material contains at least two isoflavones where one of the isoflavones is either glycitein or glycitin.Type: GrantFiled: December 13, 2002Date of Patent: December 16, 2003Assignee: Solae, LLCInventors: Doyle H. Waggle, Barbara A. Bryan
-
Publication number: 20030129263Abstract: A health supplement composition is disclosed. The health supplement composition contains a solid health supplement material that is separated from a soy molasses material. The soy molasses material is derived from a soy material selected from soy flour, soy flakes, soy grit, or soy meal. The solid health supplement material contains at least two isoflavones where one of the isoflavones is either glycitein or glycitin.Type: ApplicationFiled: December 13, 2002Publication date: July 10, 2003Applicant: Protein Technologies International, Inc.Inventors: Doyle H. Waggle, Barbara A. Bryan
-
Publication number: 20030118675Abstract: A health supplement composition is disclosed. The health supplement composition contains a solid health supplement material that is separated from a soy molasses material. The solid health supplement material contains at least two isoflavones where one of the isoflavones is either glycitein or glycitin.Type: ApplicationFiled: December 12, 2002Publication date: June 26, 2003Applicant: Protein Technologies International, Inc.Inventors: Doyle H. Waggle, Barbara A. Bryan
-
Publication number: 20030119759Abstract: A health supplement composition is disclosed. The health supplement composition contains a solid health supplement material that is separated from a soy molasses material. The solid health supplement material contains at least least two isoflavones.Type: ApplicationFiled: October 30, 2002Publication date: June 26, 2003Applicant: Protein Technologies International, Inc.Inventors: Doyle H. Waggle, Barbara A. Bryan
-
Patent number: 6579534Abstract: A composition is provided comprising a plant sterol and a soy protein material and/or and isoflavone selected from genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides, where the plant sterol comprises at least 0.49% of the composition, by weight. The present invention is also a method for decreasing the blood concentration of total and LDL cholesterol in a human in which the plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone. Also provided is a method for preventing or minimizing the development of atherosclerosis in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.Type: GrantFiled: April 4, 2001Date of Patent: June 17, 2003Assignee: Solae, LLCInventors: Doyle H. Waggle, Susan M. Potter, Edna C. Henley
-
Patent number: 6572876Abstract: A composition is provided comprising a plant sterol and a soy protein material and/or and isoflavone selected from genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides, where the plant sterol comprises at least 0.49% of the composition, by weight. The present invention is also a method for decreasing the blood concentration of total and LDL cholesterol in a human in which the plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone. Also provided is a method for preventing or minimizing the development of atherosclerosis in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.Type: GrantFiled: March 22, 2001Date of Patent: June 3, 2003Assignee: Solae, LLCInventors: Doyle H. Waggle, Susan M. Potter, E. C. Henley
-
Patent number: 6544566Abstract: A composition is provided comprising a plant sterol and a soy protein material and/or and isoflavone selected from genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides, where the plant sterol comprises at least 0.49% of the composition, by weight. The present invention is also a method for decreasing the blood concentration of total and LDL cholesterol in a human in which the plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone. Also provided is also a method for preventing or minimizing the development of atherosclerosis in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.Type: GrantFiled: April 23, 1999Date of Patent: April 8, 2003Assignee: Protein Technologies International, Inc.Inventors: Doyle H. Waggle, Susan M. Potter, E. C. Henley
-
Patent number: 6495141Abstract: Isoflavone compositions derived from soy molasses are provided. In a first embodiment, an isoflavone material derived from soy molasses containing at least two isoflavones is provided, where at least one of the isoflavones is genistein. In a second embodiment, an isoflavone material derived from soy molasses containing at least two isoflavones is provided, where at least one of the isoflavones is daidzein.Type: GrantFiled: October 19, 2001Date of Patent: December 17, 2002Assignee: Protein Technologies International, Inc.Inventors: Doyle H. Waggle, Barbara A. Bryan
-
Publication number: 20020072591Abstract: Isoflavone compositions derived from soy molasses are provided. In a first embodiment, an isoflavone material derived from soy molasses containing at least two isoflavones is provided, where at least one of the isoflavones is genistein. In a second embodiment, an isoflavone material derived from soy molasses containing at least two isoflavones is provided, where at least one of the isoflavones is daidzein.Type: ApplicationFiled: October 19, 2001Publication date: June 13, 2002Applicant: Protein Technologies International, Inc.Inventors: Doyle H. Waggle, Barbara A. Bryan
-
Patent number: 6323018Abstract: Methods for recovering isoflavones and derivatives thereof from soy molasses are disclosed. In a first embodiment, a method is disclosed in which isoflavones are recovered without any significant conversion of isoflavone conjugates to other forms. In a second embodiment, a method is disclosed whereby isoflavone conjugates are converted to glucosides while in the soy material prior to their recovery. In a third embodiment, a method is disclosed in which isoflavones are converted to their aglucone form while in the soy material and prior to their recovery. Also disclosed are various isoflavone enriched products obtained from soy molasses.Type: GrantFiled: December 3, 1998Date of Patent: November 27, 2001Assignee: Protein Technologies Int'l lnc.Inventors: Doyle H. Waggle, Barbara A. Bryan
-
Publication number: 20010029248Abstract: The present invention is a composition comprising a plant sterol and a soy protein material and/or and isoflavone selected from genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides, where the plant sterol comprises at least 0.49% of the composition, by weight. The present invention is also a method for decreasing the blood concentration of total and LDL cholesterol in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone. The present invention is also a method for preventing or minimizing the development of atherosclerosis in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.Type: ApplicationFiled: March 30, 2001Publication date: October 11, 2001Applicant: Protein Technologies International, Inc.Inventors: Doyle H. Waggle, Susan M. Potter, E. C. Henley
-
Publication number: 20010026814Abstract: The present invention is a composition comprising a plant sterol and a soy protein material and/or and isoflavone selected from genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides, where the plant sterol comprises at least 0.49% of the composition, by weight. The present invention is also a method for decreasing the blood concentration of total and LDL cholesterol in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone. The present invention is also a method for preventing or minimizing the development of atherosclerosis in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.Type: ApplicationFiled: March 22, 2001Publication date: October 4, 2001Applicant: Protein Technologies International, Inc.Inventors: Doyle H. Waggle, Susan M. Potter, Edna C. Henley
-
Publication number: 20010024666Abstract: The present invention is a composition comprising a plant sterol and a soy protein material and/or and isoflavone selected from genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides, where the plant sterol comprises at least 0.49% of the composition, by weight. The present invention is also a method for decreasing the blood concentration of total and LDL cholesterol in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone. The present invention is also a method for preventing or minimizing the development of atherosclerosis in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.Type: ApplicationFiled: April 4, 2001Publication date: September 27, 2001Applicant: Protein Technologies International, Inc.Inventors: Doyle H. Waggle, Susan M. Potter, Edna C. Henley
-
Patent number: 6132795Abstract: The present invention is a vegetable protein composition. The vegetable protein composition contains an isoflavone depleted vegetable protein material and an isoflavone containing material which is dispersed in the isoflavone depleted vegetable protein material. The composition may be used in foods to provide the nutritional benefits of the isoflavone depleted vegetable protein material while providing the health benefits of the isoflavone containing material. The invention also includes processes for forming such vegetable protein compositions.Type: GrantFiled: March 15, 1998Date of Patent: October 17, 2000Assignee: Protein Technologies International, Inc.Inventors: James L. Holbrook, Doyle H. Waggle
-
Patent number: 6083553Abstract: Methods for recovering isoflavones and derivatives thereof from soy molasses are disclosed. In a first embodiment, a method is disclosed in which isoflavones are recovered from soy molasses. In a second embodiment, a method is disclosed whereby isoflavone conjugates present in soy molasses are converted to isoflavone glucosides, and an isoflavone glucoside material is recovered from the soy molasses. In a third embodiment, a method is disclosed in which isoflavones are converted to their aglucone form, and an aglucone isoflavone material is recovered from soy molasses.Type: GrantFiled: June 5, 1998Date of Patent: July 4, 2000Assignee: Protein Technologies International, Inc.Inventors: Doyle H. Waggle, Barbara A. Bryan